MWM
MDT icon

Maltin Wealth Management’s Medtronic MDT Stock Holding History

Maltin Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,691
Closed -$409K – 123
2022
Q1 		$409K Buy
+3,691
New +$390K 0.27% 81
2020
Q3 		– Sell
-9,349
Closed -$857K – 90
2020
Q2 		$857K Buy
9,349
+602
+7% +$57.7K 0.65% 39
2020
Q1 		$789K Buy
+8,747
New +$931K 0.67% 40

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Maltin Wealth Management's MDT Position: Q2 2022 in Review

Maltin Wealth Management sold out of Medtronic (MDT) in Q2 2022, closing a stake of 3,691 shares — an estimated $409K sold.

Maltin Wealth Management first reported a position in MDT in Q1 2020 and held it in 3 quarters. The position peaked at $857K in Q2 2020. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Maltin Wealth Management reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Maltin Wealth Management sold 3,691 Medtronic shares in Q2 2022, an estimated $409K.
  • Maltin Wealth Management first reported a position in Medtronic in Q1 2020 and held it in 3 quarters.
  • Maltin Wealth Management's Medtronic position peaked at $857K in Q2 2020.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Maltin Wealth Management's 13F filing for Q2 2022, filed 5 Aug 2022.